首页> 美国卫生研究院文献>Case Reports in Gastroenterology >Carcinosarcoma of the Sigmoid Colon: Report of a Case
【2h】

Carcinosarcoma of the Sigmoid Colon: Report of a Case

机译:乙状结肠癌肉瘤:一例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Our case was a 65-year-old male, with the chief complaints of diarrhea and abdominal distention. Three years earlier, the patient had undergone transcatheter arterial embolization and radiofrequency treatment based on a diagnosis of hepatocellular carcinoma due to hepatitis B by another doctor. In October 2007, the patient developed diarrhea and increased abdominal distention. In December, CT examination conducted by the previous doctor revealed a 20-cm tumor within the pelvis. The patient was diagnosed with sigmoid colon cancer based on barium enema examination using gastrografin, and was introduced to our hospital for treatment. He was diagnosed with low-differentiated carcinoma by biopsy of the colon during endoscopy and underwent sigmoidectomy based on a diagnosis of sigmoid colon cancer. The tumor had infiltrated the bladder, and a tumorectomy was conducted through partially combined resection. The tumor was a huge lesion occupying the inside of the lumen, and histopathological findings revealed that the tumor, the main part of which lay beneath the mucous membrane, had a transitional image composed of both spindle-shaped atypical cells and sarcomatoid shape. The result of immunostaining was CK7(+), CK20(-), AFP(-), and the patient was diagnosed as having carcinosarcoma of the colon. Carcinosarcoma of the colon is a malignant tumor with poor prognosis, and the mean survival period in past reports was approximately 6 months. The patient was treated with FOLFIRI+Bevacizumab therapy according to chemotherapy for colon cancer, but he was refractory to the therapy.
机译:我们的病例是一名65岁的男性,主要主诉腹泻和腹胀。三年前,根据另一位医生对乙型肝炎引起的肝细胞癌的诊断,该患者接受了经导管动脉栓塞和射频治疗。在2007年10月,患者出现腹泻并增加了腹胀。去年12月,前一位医生进行的CT检查发现骨盆内有20厘米长的肿瘤。该患者经胃泌素钡剂灌肠检查,被诊断为乙状结肠癌,并被送往我院治疗。他在内窥镜检查中通过结肠活检被诊断为低分化癌,并根据乙状结肠癌的诊断接受了乙状结肠切除术。肿瘤浸润了膀胱,并通过部分联合切除术进行了肿瘤切除术。肿瘤是一个巨大的病变,占据了管腔的内部,组织病理学发现表明,肿瘤的主要部分位于粘膜下,具有由纺锤形的非典型细胞和肉瘤样形状组成的过渡图像。免疫染色的结果为CK7(+),CK20(-),AFP(-),并且该患者被诊断为结肠癌。结肠癌肉瘤是一种恶性肿瘤,预后较差,以往报道的平均生存期约为6个月。根据结肠癌的化学疗法,该患者接受了FOLFIRI +贝伐单抗治疗,但对治疗无效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号